Although it has been established how CD1 binds a variety of lipid antigens (Ag), data are only now emerging that show how ␣ ␤ T cell receptors (TCRs) interact with CD1-Ag. Using the structure of the human semiinvariant NKT TCR -CD1d -␣ -galactosylceramide ( ␣ -GalCer) complex as a guide, we undertook an alanine scanning mutagenesis approach to defi ne the energetic basis of this interaction between the NKT TCR and CD1d. Moreover, we explored how analogues of ␣ -GalCer affected this interaction. The data revealed that an identical energetic footprint underpinned the human and mouse NKT TCR -CD1d -␣ -GalCer crossreactivity. Some, but not all, of the contact residues within the J ␣ 18-encoded invariant CDR3 ␣ loop and V ␤ 11-encoded CDR2 ␤ loop were critical for recognizing CD1d. The residues within the V ␣ 24-encoded CDR1 ␣ and CDR3 ␣ loops that contacted the glycolipid Ag played a smaller energetic role compared with the NKT TCR residues that contacted CD1d. Collectively, our data reveal that the region distant to the protruding Ag and directly above the F pocket of CD1d was the principal factor in the interaction with the NKT TCR. Accordingly, although the structural footprint at the NKT TCR -CD1d -␣ -GalCer is small, the energetic footprint is smaller still, and reveals the minimal requirements for CD1d restriction.
␣ ␤ TCRs interact with peptide-and lipidladen MHC and CD1 molecules, respectively. The MHC is highly polymorphic, and distinct features within the peptide-binding groove enable the MHC to present a wide array of peptides to the T cells. Nevertheless, TCRs are highly specifi c and genetically restricted to recognize MHC molecules of the individual from which they were derived ( 1 ) . In contrast, CD1 family members are monomorphic glycoproteins that are recognized by T cells from diff erent individuals, and even across species in the case of CD1d. On the basis of their structural and functional features, the CD1 family is predominantly divided into group I CD1a, CD1b, and CD1c molecules, and the group II CD1d molecule, the latter of which is the only member of the family expressed in mice and rats. The Agbinding cleft of the CD1 family contains large hydrophobic pockets that are suited to bind lipid-based antigens. Recent structural studies have highlighted how diff erent-sized cavities among the CD1 family enable it to bind defi ned lipids ( 2, 3, 4 ) . For example, the CD1d family binds a restricted repertoire of glycolipids, which includes foreign glycolipids such as the glycosphingolipid ␣ -galactosylceramide ( ␣ -GalCer) ( 5 ) , which is an archetypal CD1d ligand that binds well to both human (hCD1d) and mouse CD1d (mCD1d) molecules ( 6, 7 ).
It is unclear, however, whether the principles underlying ␣ ␤ TCR -pMHC recognition will be applicable to that of ␣ ␤ TCR -CD1 interactions, and this consideration has been hampered because of a lack of structural information on ␣ ␤ TCR -CD1 -Ag complexes. Nevertheless, recent insight has been gained into lipid-mediated recognition, with the structure determination of the NKT TCR in the nonliganded state ( 25, 26 ) and in complex with CD1d -␣ -GalCer ( 27 ) . Moreover, a recent study has highlighted the important mouse NKT TCR residues that are critical for mouse CD1d-Ag recognition, although the structure of the mouse NKT TCR -CD1d -Ag complex is unknown ( 28 ) . To establish the underlying energetic basis of this human NKT TCR -CD1d -␣ -GalCer interaction, we undertook an alanine scanning approach using surface plasmon resonance, which has revealed the minimal requirements to enable CD1d-Ag recognition.
RESULTS

Experimental rationale
To defi ne the underlying energetic basis of the interaction between the NKT TCR and CD1d -␣ -GalCer, we undertook an alanine scanning approach on both the NKT TCR and CD1d binding partners. We analyzed the eff ect of the mutations on the interaction using surface plasmon resonance. Given that the structures of the NKT TCR and CD1d -␣ -GalCer are available in the nonliganded state and in complex with CD1d -␣ -GalCer, we were able to rationalize the NKT TCR and CD1d residues selected for mutational analysis. Solvent-exposed NKT TCR residues whose sidechains interacted with either CD1d and/or ␣ -GalCer were selected for substitution to alanine ( Fig. 1 A ) . CD1d residues selected for substitution were those that made contact with the NKT TCR, but were not involved in contacting ␣ -GalCer, as mutation of these latter residues (Tyr73, Ser76, Phe77, Asp80, Phe84, Asp151, Trp153, and Thr154) were considered likely to impact on the presentation of the ligand.
NKT TCR substitutions
In brief, the NKT TCR -CD1d -␣ -GalCer complex revealed that the CDR1 ␣ loop solely contacted the Ag, whereas the CDR3 ␣ loop contacted CD1d and the Ag, whereas contributions from the V ␤ chain predominantly arose via the CDR2 ␤ loop contacting CD1d ( Fig. 1 A ) . In the original study on the 3.2 Å crystal structure of NKT TCR -CD1d -␣ -GalCer complex, there were two ternary complexes within the asymmetric unit. Subtle diff erences in the NKT TCRCD1d contacts between these two ternary complexes were observed ( Table I ) , which could potentially help to further refi ne the residues important in the interaction; alternatively, these diff erences may either be a consequence of crystalpacking eff ects or be a function of refi ning a ternary complex at 3.2 Å resolution. As such, we decided to mutate all NKT TCR residues implicated in the interaction with CD1d -␣ -GalCer and in total, 14 NKT TCR amino acid substitutions Structural studies on TCR -peptide -MHC complexes have revealed markedly differing docking strategies in which TCRs can interact with peptide-MHC ligands (pMHC) ( 8, 9 ) . Nevertheless, a rough docking mode is preserved, in which the V ␣ domain is positioned over the ␣ 2-helix and the N-terminal end of the peptide, while the V ␤ domain is positioned over the ␣ 1-helix and C-terminal end of the peptide. These studies have been complemented by biophysical studies (e.g., surface plasmon resonance) of the TCR -pMHC interaction, which have demonstrated that the TCR -pMHC interaction is dominated by weak intermolecular interactions (low micromolar range), with slow association rates and fast dissociation rates ( 10, 11 ) . Moreover, alanine-scanning mutagenesis has been important in understanding the energetic basis of the TCR -pMHC interaction, and to date, has been conducted in several TCR -pMHC systems ( 12 -15 ) . These studies have revealed that the energetic contributions of the CDR loops can vary quite considerably at the TCR -pMHC interface, as well as between different TCR -pMHC systems. For example, in the 2C TCR system, the CDR1 and CDR2 loops were shown to be critically important ( 13 ) , whereas in the LC13 TCR system, the CDR3 loops contributed mostly to the energetic landscape ( 14 ) . Moreover, studies on the I-E k -moth cytochrome c system has suggested a two-step mechanism for TCR recognition of the pMHC complex, whereby the CDR1 and CDR2 loops initially contact the MHC, followed by the CDR3 loops contacting the peptide ( 15 ) .
NKT cell activation is implicated in many aspects of immunity and can enhance the response to some bacterial, viral, and parasitic infections, and some types of cancer, yet can suppress autoimmune disease, allograft rejection, and graft-versus-host disease ( 16 ) . Type I NKT cells typically express a semiinvariant ␣ ␤ TCR (NKT TCR) that comprises an invariant ␣ chain, and a limited TCR ␤ repertoire. The NKT TCR binds to CD1d, which can present self-or foreign glycolipid to NKT cells. The human invariant NKT TCR ␣ chain uses a V ␣ 24-J ␣ 18 (TRAV10-TRAJ18) rearrangement that encodes a germline-encoded junctional sequence, preserving amino acid sequence identity among human NKT TCR ␣ chains. Moreover, most type I human NKT cells express V ␤ 11 (TRBV25-1) ( 17 ) rearranged to form variable D ␤ Ϫ J ␤ combinations with N-region additions or deletions ( 18 -21 ) . In addition, some CD1d-restricted, V ␣ 24-independent NKT TCRs have been described that nevertheless maintain J ␣ 18 and V ␤ 11 usage ( 18, 22 ) , but these are less well studied. In addition to being highly selected, the human invariant NKT TCR (V ␣ 24-J ␣ 18; V ␤ 11) and the mouse NKT TCR homologue (V ␣ 14-J ␣ 18; V ␤ 8.2) ( 17 ) are cross-species reactive with mouse and human CD1d, respectively ( 23, 24 ) . Such evolutionary conserved recognition is contrary to the highly restricted syngeneic TCR recognition of MHC class I and II molecules.
panel of conformation-sensitive mAbs reactive against regions of the V ␣ 24 (A2G10) and V ␤ 11 (1A6 and A2G6) variable domains and the TCR constant domain (12H8). However, the Pro28 ␣ Ala mutant was the exception, as there was no reactivity with the V ␣ 24 (A2G10) mAb, but equal reactivity with mAbs toward the V ␤ 11 (1A6 and A2G6) and constant domain (12H8). Accordingly, the controls were consistent with the NKT TCR mutants; with the exception of Pro28 ␣ , they all retained their native conformation (unpublished data).
Varying concentrations of the NKT TCR were passed over a research-grade streptavidin sensor chip (GE Healthcare) coupled with biotinylated mouse or human CD1d loaded with ␣ -GalCer and the corresponding unloaded equivalents. The fi nal response was determined by subtracting the unloaded CD1d response from the CD1d -␣ -GalCer response and the equilibrium binding constant ( K deq ) was calculated ( Fig. 2, A -C ) . The interaction of WT NKT TCR and human CD1d -␣ -GalCer had a K deq of ‫ف‬ 0.5 ± 0.05 μ M, whereas the K deq for mouse CD1d -␣ -GalCer was ‫ف‬ 0.9 ± 0.13 μ M ( Table I ) and were broadly consistent with previous measurements ( 25, 26 ) . Although these WT K deq measurements were reproducible on two separate occasions and using two separate batches of WT NKT TCR, we nevertheless considered it important that all the mutant NKT TCR proteins were analyzed in the same experiment, in duplicate and relative to the same batch of WT NKT TCR. This was to ensure that all the K deq values were comparable and relative to one another ( Table I ) . NKT TCR substitutions that caused less than a fourfold loss in the affi nity of the interaction with CD1d -␣ -GalCer compared with WT NKT TCR were considered to have no major eff ect. NKT TCR substitutions that caused more than a 10-fold loss in binding affi nity were considered crucial to the energetics of the interaction. In each instance, the eff ect of the NKT TCR substitution on the affi nity of the interaction was essentially consistent between mouse and human CD1d -␣ -GalCer.
The CDR1 ␣ loop
We mutated Pro28 ␣ and Ser30 ␣ within the CDR1 ␣ loop, both of which interact exclusively with the galactose moiety of ␣ -GalCer ( Fig. 1 B ) . The Ser30 ␣ Ala substitution did not alter the affi nity of the interaction with hCD1d -␣ -GalCer, even though it forms H-bonds and van der Waals (vdw) contacts with the 3 Ј -and 4 Ј -hydroxyls of the galactose moiety, respectively ( Fig. 1 B ) . This lack of eff ect was surprising, as the mouse NKT TCR can distinguish between ␣ -GalCer analogues that possess minor structural modifi cations on the saccharide, such as the positioning of the 2 Ј and 4 Ј hydroxyls in ␣ -ManCer ( 29 ) . Although the Ser at position 30 is not conserved in the mouse NKT TCR homologue, the equivalent substitution in the mouse system (Asn30 ␣ → Ala) resulted in a greater than twofold loss of binding of mCD1d tetramers loaded with ␣ -GalCer and the ␣ -GalCer analogues PBS57 and OCH9 ( 28 ) .
were made and included CDR1 ␣ (Pro28 ␣ and Ser30 ␣ ); CDR3 ␣ (Asp94 ␣ , Arg95 ␣ , Gly96 ␣ , Ser97 ␣ , Thr98 ␣ , Leu99 ␣ , and Arg103 ␣ ); CDR2 ␤ framework (Tyr48 ␤ and Glu56 ␤ ); CDR2 ␤ (Tyr50 ␤ and Asn53 ␤ ); and CDR3 ␤ (Tyr103 ␤ ). All of the mutant NKT TCR proteins expressed and refolded with similar yield to WT NKT TCR, except for Asp94 ␣ , which produced half the amount of protein during expression but has the same refold effi ciency as the WT. These mutant NKT TCR proteins behaved similarly to the WT NKT TCR in gel fi ltration and analysis under reducing and nonreducing SDS-PAGE. Furthermore, the NKT TCR mutant proteins were as reactive as the WT NKT TCR to a Fig. 1 (B -E) , substituted residues with a > 10-fold reduction in affi nity are shown in red; with a 4 -6-fold reduction in affi nity are shown in green; and with a < 4-fold reduction in affi nity are shown in blue.
Gly96 ␣ Ala substitution was surprising, however, as the main chain of Gly96 ␣ H-bonded to the 2 Ј -OH of ␣ -GalCer and also interacted with the 3 Ј -OH of ␣ -GalCer and residues within the ␣ 2-helix of CD1d. Nevertheless, four (Asp94 ␣ , Arg95 ␣ , Ser97 ␣ , and Leu99 ␣ ) of the seven residues substituted within the CDR3 ␣ loop of the NKT TCR had a marked eff ect on the affi nity of the interaction with hCD1d -␣ -GalCer ( Table I and Fig. 1 C ) . The substitutions at these critical positions would result in the loss of saltbridging interactions with Arg79 and Asp80, and vdw interactions with Ser76 from the ␣ 1-helix of CD1d, as well as vdw interactions with residues from the ␣ 1-and ␣ 2-helices of CD1d. Accordingly, some, but not all of the residues in the strictly conserved J ␣ 18 gene are critically important in the recognition of CD1d.
The CDR3 ␤ loop Tyr103 ␤ , which is located on the J ␤ gene segment of the CDR3 ␤ loop of the NKT TCR, is the sole CDR3 ␤ residue that contacts CD1d. The Tyr103 ␤ Ala substitution resulted in the loss of a vdw contact with the ␣ 2-helix of Pro28 ␣ contacts the 6 Ј -OH and 5 Ј -O of the galactose moiety of ␣ -GalCer. Although the Pro28 ␣ Ala substitution had a marked eff ect on the affi nity of the interaction with hCD1d -␣ -GalCer, our mAb reactivity data suggests the Pro28 ␣ Ala substitution had an overall eff ect on the conformational integrity of the V ␣ 24 domain of the NKT TCR, making it diffi cult to determine whether this substitution was important in the interaction.
The CDR3 ␣ loop Seven mutations were made in this loop ( Table I and Fig. 1 , A and C ), three of which (Gly96 ␣ , Thr98 ␣ , and Arg103 ␣ ) had a negligible eff ect on the affi nity of the interaction. The lack of an eff ect with the Thr98 ␣ Ala substitution was not surprising, as the cross-reactive mouse NKT TCR possesses an Ala at that position ( Fig. 3 A ) . Even though Arg103 ␣ is conserved in the mouse NKT TCR homologue, its substitution to Ala had no eff ect on the recognition of hCD1d -␣ -GalCer. This residue forms an H-bond with the Arg79 on the ␣ 1-helix of CD1d in one ternary complex within the asymmetric unit ( Table I ). The lack of eff ect of the The CDR2 ␤ loop The CDR2 ␤ loop dominated contacts from the V ␤ 11 chain of the NKT TCR. Four residues within or surrounding this loop were mutated, but only two of these residues, Tyr48 ␤ and Tyr50 ␤ , were critical to the energetics of the interaction. These residues are conserved within the mouse NKT TCR homologue and H-bonded to Glu83 and Lys86, as well as forming vdw interactions with residues from the ␣ 1-helix ( Fig. 1 E ) . Asn53 ␤ and Glu56 ␤ were shown to be nonessential residues in the interaction. Accordingly, only two aromatic residues within and next to the CDR2 ␤ loop are critical for the interaction with CD1d -␣ -GalCer.
CD1d substitutions
Based on the crystal structure of the NKT TCR -CD1d -␣ -GalCer complex, six " alanine-scanning " CD1d mutants were produced, including Arg79, Glu83, Lys86, and Met87 on the CD1d ␣ 1-helix and Val147 and Gln150 on the ␣ 2-helix. The CD1d mutant proteins were expressed at similar levels to WT CD1d, behaved similarly under reducing and nonreducing SDS-PAGE, and were as reactive in an ELISA probed with anti -human CD1d mAb 51.1 (unpublished data) ( 30 ) . CD1d proteins were biotinylated, loaded, and coupled to a research-grade streptavidin sensor chip and analyzed for their reactivity against varying concentrations of the WT NKT TCR after the subtraction of the unloaded CD1d response ( Fig. 2 D ) . The eff ect of the CD1d substitutions can be grouped into the following three categories: no eff ect, a moderate eff ect of 4 -6-fold loss of affi nity, and a drastic eff ect of > 10-fold loss of affi nity ( Table II ) . Arg79, which contacts three residues within the J ␣ 18 region, was the only CD1d residue whose substitution had no eff ect on the interaction with the NKT TCR ( Table II ) . Two of the substitutions that had the greatest impact on affi nity included Glu83 and Met87, which are both located on the ␣ 1-helix of CD1d. These substitutions would result in a loss of contacts with Tyr48 ␤ and Tyr50 ␤ on the CDR2 ␤ loop, thereby correlating with the CDR2 ␤ mutagenesis ( Table I ) . Consistent with our observation, a mouse CD1d transfectant bearing an Ala substitution at position 83 showed impaired stimulation of semiinvariant mouse NKT cells ( 31, 32 ) . In addition, Lys86 contacts Tyr48 ␤ from the CDR2 ␤ loop and also salt bridges to Glu56 ␤ , and the Lys86 to Ala substitution had a moderate eff ect on the interaction with the NKT TCR.
Two CD1d residues located on the ␣ 2-helix (Val147 and Gln150) were substituted, and each had a moderate eff ect on the affi nity of the interaction with the NKT TCR ( Table II ) . Both contacted residues within the highly selected J ␣ 18 segment of the NKT TCR, with the former making vdw contacts with Ser97 ␣ and Leu99 ␣ , and the latter with Gly96 ␣ , Ser97 ␣ , Thr98 ␣ , and Tyr103 ␤ . The eff ect of the Val147 to Ala mutant concurs with the NKT TCR mutagenesis data, whereby the reciprocal substitutions of both Ser97 ␣ and hCD1d, but this loss was inconsequential to the affi nity of the interaction with hCD1d -␣ -GalCer, further highlighting the lack of a role of the CDR3 ␤ loop of this NKT TCR in the interaction with CD1d -␣ -GalCer ( Fig. 1 D ) . ( Fig. 4 A ) . The substitutions that had a marked eff ect on the affi nity of the interaction formed a central hotspot over the surface of the antigen-binding domain, whereas noncritical residues were located peripheral to the hotspot ( Fig. 4 A ) . The hotspot included some of the residues from the CDR3 ␣ loop (Asp94 ␣ , Arg95 ␣ , Ser97 ␣ , and Leu99 ␣ ), residues from within or surrounding the CDR2 ␤ loop (Tyr48 ␤ and Tyr50 ␤ ).
Similarly, to defi ne CD1d residues that were critical to the NKT TCR interaction, we mapped the residues that were substituted in this study, highlighting residues that formed crucial contacts with the NKT TCR ( Fig. 4 B ) . The CD1d
Leu99 ␣ resulted in a marked loss of recognition of CD1d -␣ -GalCer. On the other hand, not all of the NKT TCR contacts of CD1d residue Gln150 were detrimental to the recognition event when they themselves were substituted. Indeed, only the Ser97 ␣ substitution caused a loss, again highlighting the important role of this CDR3 ␣ residue.
The energetic hotspots
Next, we mapped the location of NKT TCR residues that were substituted in this study onto the structure of the NKT TCR to ascertain the location and size of the energetic hotspot 3.6 ± 0.17 Ser97 ␣ , Leu99 ␣ J ␣ ** Gln150A 2.5 ± 0.19 Gly96 ␣ , Ser97 ␣ , Thr98 ␣ , Tyr103 ␤ J ␣ ** * represents CD1d alanine substitution with < 4-fold reduction in binding to NKT TCR compared to the WT value; ** represents CD1d alanine substitution resulting in a 4 -6-fold reduction in binding to NKT TCR compared to the WT value; and *** represents CD1d alanine substitution resulting in a > 10-fold reduction in binding to NKT TCR compared to the WT value. a Conserved between human and mouse CD1d. b Denotes contacts that are not maintained in the second NKT TCR -CD1d -␣ -GalCer complex within the asymmetric unit.
CD1d ␣ 1-and ␣ 2-helix, including Lys86, Val147, and Gln150, also caused a moderate loss in the affi nity of the interaction. Collectively, these and previous mutagenesis results indicate that the CD1d energetic footprint is localized and centrally located above the F Ј pocket of CD1d ( Fig. 4, B and C ) .
Cross-species reactivity
In addition to examining the eff ect of the 14 NKT TCR mutations on the interaction with hCD1d, we also examined the eff ect of these mutations on the interaction with mCD1d -␣ -GalCer ( Table I ) . Although the interaction with mCD1d was consistently approximately twofold weaker when compared with hCD1d, the eff ect of the NKT TCR mutations on the mCD1d interaction essentially parallelled that observed in our hCD1d -␣ -GalCer study ( Table I ) . Moreover, of the six residues that were important in the NKT TCR, Asp94 ␣ , Arg95 ␣ , Ser97 ␣ , Leu99 ␣ , Tyr48 ␤ , and Tyr50 ␤ are all conserved in the mouse V ␣ 14J ␣ 18-V ␤ 8.2 NKT TCR ( Table I and Fig. 3 A ) . Consistently, mouse NKT cells expressing TCRs with these identical individual substitutions (with the exception of Tyr48 ␤ , which was not tested) had a marked reduction in mCD1d -␣ -GalCer tetramer binding ( 28 ) . Furthermore, of the fi ve CD1d residues that had a moderate-to-marked eff ect on the binding of the NKT TCR (Glu83, Lys86, Me87, Val147, and Gln150), all but one are conserved in the mouse CD1d homologue (Gln150 to Ala 152; Table II and Fig. 3 B ) . Collectively, these results indicate that a similar footprint underpins the human -mouse cross-species reactivity, which is reinforced by sequence and structural analyses.
␣ -GalCer analogues
Having shown which NKT TCR residues are required to interact with hCD1d, and that a common structural footprint underpins the reciprocal cross-species reactivity, we then probed the role of the CDR1 ␣ loop in interacting with the ␣ -GalCer. Given that the majority of the CDR1 ␣ -mediated interactions are with the 3 Ј -and 4 Ј -hydroxyl groups of ␣ -GalCer, we used ␣ -GalCer analogues deficient in either one of these groups. First, we used mouse CD1d tetramers loaded with the ␣ -GalCer analogues and assessed the role these modifi cations had on the staining of cells expressing the WT mNKT TCR and CDR1 ␣ mutants thereof ( Fig. 5 ) . The data indicated that WT mNKT TCR could interact with all three analogues of ␣ -GalCer in the following order: ␣ -GalCer > 4 Ј -deoxy ≈ 3 Ј -deoxy. Of the alanine-scanning mutations, positions 26 and 28 are likely to aff ect the conformation and/or mobility of the CDR1 ␣ loop, thereby highlighting the overall importance of the conformation of this loop in recognition of ␣ -GalCer. Positions 29, 32, and 33 are, by analogy to the human NKT TCR -CD1d complex, unlikely to participate in contacting ␣ -GalCer, and this was evident from the mutagenesis data. However, the substitutions at positions substitutions that caused the greatest loss of NKT TCR recognition included Glu83 and Met87, indicating the disruption of contacts with the ␣ 1-helix were the most critical. However, the substitution of other residues on the Substituted residues that have > 10-fold reduction in affi nity are shown in red; 4 -6-fold reduction in affi nity are shown in green; < 4-fold reduction in affi nity are shown in blue; residues that were not substituted are shown in purple; ␣ -GalCer is shown in pink; CDR1 ␣ loop is shown in yellow; CDR3 ␣ is shown in cyan; CDR2 ␤ loop is shown in orange; CDR3 ␤ loop is shown in blue; and CD1d ␣ -helices are shown in grey.
30 and 31 of the mNKT TCR are likely to be more specifi c in the disruption of contacts with CD1d -␣ -GalCer. Overall, the mutations indicate that substitutions at the 3 Ј -OH are less well tolerated than substitutions at the 4 Ј -OH for ␣ -GalCer. Furthermore, to account for the sequence variation between the mouse and human CDR1 ␣ loops, we reverted single substitutions within the mouse NKT TCR CDR1 ␣ loop back to their human counterpart, i.e., Asn30 ␣ Ser and His31 ␣ Asn and also the double Ser-Asn mutant at positions 30 and 31. In comparison to the alanine-scanning mutants, the binding affi nity of these mutants was more comparable to the WT mNKT TCR, indicating that the sidechains at positions 30 and 31 contribute some energy, albeit modest, to the interaction ( Fig. 5 ) . For example, the hNKT TCR -CD1d -␣ -GalCer structure reveals that Ser30 ␣ H-bonded to the 3 Ј -OH of ␣ -GalCer. This is consistent with the Asn30Ser mutant not being able to rescue binding to the 3 Ј -deoxy derivative of ␣ -GalCer, yet can partially improve the binding affi nity of the 4 Ј -deoxy derivative. Interestingly, the Asn30Ala mutant appeared to aff ect the binding to the 3 Ј -and 4 Ј -deoxy derivatives of ␣ -GalCer ( Fig. 5 ) , which, unlike Ser30 ␣ of hNKT TCR, suggests that Asn30 of mNKT TCR forms H-bonds to both these moieties, which would be consistent with its longer sidechain.
DISCUSSION
At a structural level, the vast T cell repertoire is manifested in the various ways in which a TCR can interact with the polymorphic pMHC. Despite the repertoire diversity, examples of TCR bias have emerged in antiviral immunity, and such biased TCR usage has been correlated with the recognition of atypical pMHC landscapes ( 33 ) . The human semiinvariant NKT TCR is an example of biased TCR usage directed against a monomorphic CD1d molecule, in which the NKT TCR ␣ chain is invariant and the ␤ chain is restricted to V ␤ 11 usage, albeit with variable CDR3 ␤ usage. In comparison to the previously determined TCR -pMHC complexes, the NKT TCR adopted an unusual docking strategy to interact with the featureless CD1d -␣ -GalCer complex ( 27 ) . We therefore sought to determine the energetic landscape of the NKT TCR -CD1d -␣ -GalCer interaction.
Our observations demonstrate that although the NKT TCR structural footprint is small, the energetic footprint is smaller still, as not all of the residues of the NKT TCR that mediated contacts with CD1d -␣ -GalCer contributed to the energetic landscape of the interaction. Namely, we substituted 14 residues of the NKT TCR that contact CD1d -␣ -GalCer and of these, only 6 contributed to the energetic Figure 5 . ␣ -GalCer analogues. (A) Hybridomas expressing wild-type mouse V ␣ 14i TCR ␣ chain were subjected to staining with the indicated dilutions of mouse CD1d tetramers left unloaded or loaded with ␣ -GalCer, 3 Ј deoxy-␣ -GalCer, or 4 ' deoxy-␣ -GalCer, and mean fl uorescence intensity (MFI) of tetramer staining was determined from a thin TCR gate. MFI of background staining with unloaded tetramer was determined for each concentration and subtracted from the MFI of loaded tetramer. Data points represent the mean of MFI ± the range from two independent experiments. (B) Hybridomas expressing WT or indicated mutations of mouse V ␣ 14i TCR ␣ chain were subjected to staining with mouse CD1d tetramers loaded with ␣ -GalCer (top), 3 Ј deoxy-␣ -GalCer (middle), or 4 ' deoxy-␣ -GalCer (bottom). Nonmutated V ␣ 14-J ␣ 18 TCR ␣ chain served as the WT control. The negative control was a V ␣ 14-J ␣ 18 construct in which the V ␣ 14 CDR1 region was swapped for the V ␣ 3.2 CDR1 ␣ region (V ␣ 3.2). MFI of tetramer staining for all mutants was determined from a thin TCR gate. Error bars represent the mean of MFI ± the range for two independent experiments. a greater infl uence on the recognition of other ligands bound to CD1d, and this was analyzed using analogues of ␣ -GalCer. It was clear that the mNKT TCR could interact with the 3 Ј -and 4 Ј -deoxy-galactosyl ceramides, which is consistent with the hNKT TCR CDR1 ␣ mutagenesis ( Table I ) . Nevertheless, the alanine-scanning and " humanized " mutagenesis on the CDR1 ␣ loop indicated that removal of the 4 Ј -OH moiety was more tolerated than the 3 Ј -OH substitution. The apparent adaptability of the CDR1 ␣ -␣ -GalCer interactions is consistent not only with the relatively low sequence conservation in the CDR1 ␣ loop between the mouse and human NKT TCRs ( 17 ) , but also the presence of some CD1d-restricted, ␣ -GalCer -reactive, V ␣ 24-negative NKT TCRs that diff er in the sequence of the CDR1 ␣ loop ( 22, 26 ) .
In contrast to TCR -pMHC interactions, the NKT TCR exhibits reciprocal cross-species reactivity, and the eff ects of the NKT TCR mutations display an identical pattern when interacting with human CD1d or mouse CD1d, suggesting that the human NKT TCR will dock in a very similar manner on mouse CD1d compared with human CD1d. The similarity of the human NKT TCR footprint on both mouse and human CD1d molecules appears to engender reciprocal cross-reactivity. In summary, the markedly diff erent docking strategies between TCR -pMHC and TCR -CD1d complexes are also mirrored by diff erences in the energetic footprints between peptide and glycolipidrestricted TCRs.
MATERIALS AND METHODS
Protein expression, refolding, and purifi cation. The cloning, expression, and purifi cation of the human NKT TCR used in this study ( ␣ chain: TRAV10-TRAJ18; ␤ chain TRBV25-1, TRBD1 and TRBJ2-7, with CDR3 ␤ sequence 92 CASS 95 96 GLRDRGL 102 103 Y 105 EQYFG-PGTRLTVT 117 ; and NKT15) has been previously described ( 25 ) . However, the NKT TCR proteins were further purifi ed using hydrophobic interaction chromatography and a Phenyl HP HiTrap column (GE Healthcare). The NKT TCR was eluted with 20 mM Hepes, pH 7.4, and 0.8 M ammonium sulfate, concentrated, and buff er-exchanged into 10 mM Hepes, pH 7.4, 150 mM NaCl using a 30K Amicon Ultra-4 concentrator (Millipore). The cloning, expression, purifi cation, biotinylation, and loading of human CD1d have been previously described ( 25 ) . Purifi ed, biotinylated mouse CD1d was supplied by D. Pellicci (University of Melbourne, Parkville, Victoria, Australia) and was generated using a construct originally provided by M. Kronenberg (University of Melbourne).
NKT TCR mutants. The WT human NKT TCR ␣ -or ␤ chain DNA was used as the template to generate the NKT TCR mutants using site-directed mutagenesis (QuikChange; Stratagene). A total of 14 mutant NKT TCR mutant proteins were made, each coding for a single amino acid substitution to Ala, and each was expressed and purifi ed as per the WT human NKT TCR.
CD1d mutants. WT CD1d DNA coding for a free C-terminal Cys was used to generate six CD1d mutants using site-directed mutagenesis. The CD1d mutant proteins each contained a single alanine substitution and were expressed in the baculovirus expression system. The mutant proteins were purifi ed, biotinylated, and loaded as per WT CD1d, and then coupled to a SA sensor chip for surface plasmon resonance analysis with WT NKT TCR. Anti-NKT TCR mAbs were provided by N. Crowe, K. Kyparissoudis, and D. Pellicci (University of Melbourne). footprint, with the CDR3 ␣ and CDR2 ␤ loops of the NKT TCR appearing to be the principal driving force of the interaction. The requirement of the CDR3 ␣ loop in the energetics of the interaction argues against the twostep model in TCR-CD1d recognition. The NKT TCR and CD1d substitution results reveal that although only a few contacts are mediated via the V ␤ domain, Tyr48 ␤ , Tyr50 ␤ , and the corresponding binding partners on CD1d are absolutely critical to the interaction. These two V ␤ residues have been identifi ed as " recognition codons " in class II -restricted mouse TCRs using the human V ␤ 11 chain homologue V ␤ 8.2. The recognition codons are implicated in restricting and defi ning the binding orientation of the TCR onto the MHC by penetrating between residues on the MHC helices ( 34 ) . The general use of Tyr48 ␤ and Tyr50 ␤ highlights a potential evolutionary role of the NKT TCR CDR2 ␤ loop for CD1d binding and the use of recognition codons for MHC-like molecules, although it should be noted that the " interaction codon " sites in MHC and CD1d do not reside within structurally equivalent regions ( 35 ) .
Although some residues from within the CDR3 ␣ loop were also deemed critical for the interaction with CD1d, Arg95 ␣ was the only energetically important residue that interacts with the Ag. Accordingly, NKT TCR residues interacting with the CD1d seemingly had a greater eff ect on the energetics of the interaction than those directly contacting the glycolipid ligand, at least in the case of ␣ -GalCer. However, this fi nding is anomalous given that ␣ -GalCer is a requirement for the staining of NKT cells by CD1d Ϫ ␣ -GalCer tetramers and for NKT cell activation. This suggests that the ␣ -GalCer ligand may play a less direct role in the NKT TCR interaction and a more prominent role in infl uencing the conformation of residues on CD1d, which in turn may infl uence NKT TCR recognition. Indeed, a comparison of liganded versus unliganded CD1d -␣ -GalCer ( 36 ) shows that four CD1d residues change conformation upon ligation, and all are located on a small stretch of the ␣ 1-helix just above the F Ј pocket. Furthermore, our CD1d substitution analysis revealed two residues that had a drastic eff ect on the interaction with the NKT TCR (Glu83 and Met87) and both are located on the ␣ 1-helix above the F Ј pocket. Consistent with this notion, the conformation of CD1d has been proposed to modulate the affi nity of the mouse NKT TCR to two ligands (OCH9 and ␣ -GalCer) that diff er only in the length of the predominantly buried sphingosine chain ( 37 ) .
The apparent lesser contribution of the CDR1 ␣ loop was surprising, as this loop solely contacted the ␣ -GalCer, and the loss of binding caused by the Pro28 ␣ Ala substitution may be attributable to local changes in the conformation of the loop. However, we cannot exclude the possibility that redundancy exists in the interactions between residues containing ␣ -GalCer that would not have been detected in our single amino acid mutagenesis studies. It also remains possible that substitutions within this loop may have ELISA. The conformational integrity of the CD1d and NKT TCR proteins was determined using an ELISA and relevant conformation-specifi c mAbs. The integrity of the CD1d proteins was determined using an antihuman CD1d mAb 51.1 ( 30 ) , whereas the conformation of the NKT TCR proteins was determined using a panel of mAbs including a V ␣ 24-reactive mAb (A2G10), two V ␤ 11-reactive mAbs (A2G6; 1A6), and a pan-soluble ␣ ␤ TCR-reactive mAb (12H8). ELISA plates were coated with the CD1d or NKT TCR proteins at 5 or 10 μ g/ml, respectively, and tested against serial dilutions of the relevant mAbs. The ELISA was then probed with HRP anti -mouse IgG, followed by OPD substrate, and the ELISA plate read at 492 nm. WT CD1d and NKT TCR proteins were used as positive controls, whereas a recombinant V ␣ 24 Ϫ V ␤ 11 Ϫ TCR, together with its cognate peptide-MHC ligand, was included as a negative control. All experiments were performed at least in duplicate.
Surface plasmon resonance measurements and analysis. Equilibrium affi nity measurements of the NKT TCR -CD1d -␣ -GalCer interaction were determined by surface plasmon resonance and have been previously described ( 25 ) . For the NKT TCR mutant analysis, ‫ف‬ 3,000 RU of biotinylated WT human and mouse CD1d were coupled to a SA sensor chip (GE Healthcare) and analyzed against twofold serial dilutions of the WT and mutant NKT TCR. For the CD1d mutant analysis, ‫ف‬ 3,000 RU of human mutant or WT CD1d protein was coupled to a SA sensor chip and analyzed against the WT NKT TCR. For both experiments, the analyte was passed over the sensor chip at 5 μ l/min for 80 s at 25 ° C, and the fi nal response was subtracted from that of unloaded CD1d.
Staining of hybridomas expressing mouse V ␣ 14i TCRs. Hybridomas expressing WT or mutant mouse V ␣ 14i TCR chains were generated by retroviral transduction of a hybridoma expressing only the DO-11.10 V ␤ 8.2 TCR ␤ chain, as previously described ( 28 ) . For staining with mouse CD1d tetramers, unloaded, biotinylated recombinant CD1d protein was provided by the National Institutes of Health core facility. For multimerization, monomeric biotinylated recombinant CD1d was incubated overnight with ␣ -GalCer, C3 Ј -deoxy-␣ -GalCer, or C4 Ј deoxy-␣ -GalCer in PBS and 0.05% Tween 20, followed by addition of streptavidin (SA)-PE. TCR-expressing hybridomas were costained at room temperature for 60 min with indicated tetramer plus anti-TCR ␤ (H57-597; eBioscience) and data were acquired on a FACSCalibur or FACScan fl ow cytometer (BD Biosciences). Data fi les were analyzed using FlowJo software (Tree Star, Inc.) and mean fl uorescence intensity was compared for all samples on a narrow TCR gate, as previously described ( 28 ) .
